Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Jacob P Hoj
Affiliation
Duke University
ORCID
Career Start Year
2014
Papers
15
H Index
7
Expertise
CM4AI Collaborator
Antoine Forget (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36711936
MCB-613 exploits a collateral sensitivity in drug resistant <i>EGFR</i>-mutant non-small cell lung cancer through covalent inhibition of KEAP1.
bioRxiv
2023
37882674
Activation of KrasG12D in Subset of Alveolar Type II Cells Enhances Cellular Plasticity in Lung Adenocarcinoma.
Cancer Res Commun
2023
37781087
ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination.
Neurooncol Adv
2023
37493631
CBF-Beta Mitigates PI3K-Alpha-Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer.
Mol Cancer Res
2023
37040401
ABL kinases regulate the stabilization of HIF-1α and MYC through CPSF1.
Proc Natl Acad Sci U S A
2023
36918588
Executioner caspases restrict mitochondrial RNA-driven Type I IFN induction during chemotherapy-induced apoptosis.
Nat Commun
2023
35668193
P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia.
Nat Cancer
2022
34706244
ABL allosteric inhibitors synergize with statins to enhance apoptosis of metastatic lung cancer cells.
Cell Rep
2021
33119681
Mesenchymal stem cells promote metastasis through activation of an ABL-MMP9 signaling axis in lung cancer cells.
PLoS One
2020
33318173
The ABL2 kinase regulates an HSF1-dependent transcriptional program required for lung adenocarcinoma brain metastasis.
Proc Natl Acad Sci U S A
2020
31213459
The Evolving Modern Management of Brain Metastasis.
Clin Cancer Res
2019
31825826
A TAZ-AXL-ABL2 Feed-Forward Signaling Axis Promotes Lung Adenocarcinoma Brain Metastasis.
Cell Rep
2019
29433928
Pharmacology and in vivo efficacy of pyridine-pyrimidine amides that inhibit microtubule polymerization.
Bioorg Med Chem Lett
2018
28780159
Pyridine-pyrimidine amides that prevent HGF-induced epithelial scattering by two distinct mechanisms.
Bioorg Med Chem Lett
2017
24780819
Cellular contractility changes are sufficient to drive epithelial scattering.
Exp Cell Res
2014
1 - 15 of 15
Column Actions
Search
Recommended Authors
Shruthy Suresh
Memorial Sloan Kettering Cancer Center
Career Start Year
2013
Number of shared co-authors
0
Victor Olivas
University of California san francisco
Career Start Year
2012
Number of shared co-authors
0
Myung Chang Lee
Stanford University
Career Start Year
2012
Number of shared co-authors
0
Daniel J McGrail
Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic
Career Start Year
2012
Number of shared co-authors
0
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year
2010
Number of shared co-authors
0
Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year
2010
Number of shared co-authors
0
Chad V Pecot
University of North Carolina at Chapel Hill
Career Start Year
2009
Number of shared co-authors
1
Joshua C Anderson
University of Alabama at Birmingham
Career Start Year
2005
Number of shared co-authors
0
Jalna Meens
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2004
Number of shared co-authors
0
Anita B Hjelmeland
University of Alabama at Birmingham
Career Start Year
2004
Number of shared co-authors
0
Arnulfo Mendoza
National Cancer Institute, National Institutes of Health
Career Start Year
2004
Number of shared co-authors
0
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year
2003
Number of shared co-authors
0
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year
2003
Number of shared co-authors
0
Elena Ivanova
Dana-Farber Cancer Institute
Career Start Year
2003
Number of shared co-authors
0
Trever G Bivona
University of California san francisco
Career Start Year
2002
Number of shared co-authors
4
Christopher D Willey
University of Alabama at Birmingham
Career Start Year
2000
Number of shared co-authors
0
Andrea Bertotti
Candiolo Cancer Institute - FPO IRCCS
Career Start Year
2000
Number of shared co-authors
2
Chandra C Ghosh
The Wistar Institute
Career Start Year
1999
Number of shared co-authors
0
Monika A Davare
Oregon Health Sciences University
Career Start Year
1998
Number of shared co-authors
0
Peter S Hammerman
Novartis Institutes for BioMedical Research
Career Start Year
1996
Number of shared co-authors
0
John D Gordan
Quantitative Biosciences Institute (QBI), University of California San Francisco
Career Start Year
1996
Number of shared co-authors
0
Shi-Yuan Cheng
Northwestern University Feinberg School of Medicine
Career Start Year
1996
Number of shared co-authors
0
Krister Wennerberg
University of Copenhagen
Career Start Year
1994
Number of shared co-authors
4
Michael Peyton
Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center
Career Start Year
1994
Number of shared co-authors
0
Livio Trusolino
Candiolo Cancer Institute - FPO IRCCS
Career Start Year
1993
Number of shared co-authors
2
Andrei Goga
University of California San Francisco
Career Start Year
1993
Number of shared co-authors
0
Frank B Furnari
University of California San Diego
Career Start Year
1992
Number of shared co-authors
0
Charles M Rudin
Memorial Sloan Kettering Cancer Center
Career Start Year
1989
Number of shared co-authors
0
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year
1989
Number of shared co-authors
1
Lori S Hart
Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research
Career Start Year
1987
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Kris C Wood
Duke University
Co-authored papers
6
Kevin H Lin
Duke University
Co-authored papers
3
Christopher F Bassil
Duke University School of Medicine Durham
Co-authored papers
2
Peter S Winter
Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School
Co-authored papers
2
Jiaxing Lin
Peking University People's Hospital
Co-authored papers
2
Alexandre Puissant
Universite de Paris, INSERM, CNRS
Co-authored papers
2
Patrick Auberger
Universite Cote d'Azur, INSERM U5
Co-authored papers
2
Hazel X Ang
Duke University School of Medicine
Co-authored papers
2
Paul-Arthur Meslin
Universite de Paris, INSERM, CNRS
Co-authored papers
1
Zachary J Reitman
Co-authored papers
1
Antoine Forget (CM4AI)
University of California San Francisco
Co-authored papers
1
Gaetano Sodaro
Universite Paris Cite, INSERM, CNRS
Co-authored papers
1
Nina Fenouille
Universite Paris Cite, INSERM, CNRS
Co-authored papers
1
Florence M G Cavalli
Institut Curie, PSL Research University
Co-authored papers
1
Camille Vaganay
Universite de Paris, INSERM, CNRS
Co-authored papers
1
Lina Benajiba
Universite de Paris, Inserm CIC 1427
Co-authored papers
1
David A Rizzieri
Duke University Medical Center
Co-authored papers
1
Xinghai Li
Duke University
Co-authored papers
1
Gray R Anderson
Duke University
Co-authored papers
1
Timothy S Pardee
Comprehensive Cancer Center of Wake Forest Baptist Health, Medical Center Boulevard
Co-authored papers
1
Frank Ling
Universite de Paris, INSERM, CNRS
Co-authored papers
1
Zhecheng Sheng
Duke University
Co-authored papers
1
Raphael Itzykson
Universite Paris Cite, INSERM, CNRS
Co-authored papers
1
Abigail Xie
Duke University
Co-authored papers
1
Mariaelena Pierobon
Center for Applied Proteomics and Molecular Medicine, George Mason University
Co-authored papers
1
Ashutosh Chilkoti
Duke University
Co-authored papers
1
Rachel Washart
Duke University
Co-authored papers
1
Chaima Benaksas
Universite de Paris, INSERM, CNRS
Co-authored papers
1
Paul Chaintreuil
Universite Cote d'Azur, Institut National de la Sante et de la Recherche Medicale
Co-authored papers
1
Carey K Anders
Co-authored papers
1
1 - 30